Community-Acquired Pneumonia (CAP) Surveillance

Community-Acquired Pneumonia (CAP) Mycoplasma Surveillance

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01416506

Enrollment

560

Registered

2011-08-15

Start date

2010-09-30

Completion date

2013-01-31

Last updated

2013-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pneumonia

Keywords

Pneumonia, surveillance

Brief summary

Prospective, non-interventional, multi-center study. 7 investigative centers will involved in China. Around 560 CAP outpatients or inpatients will be screened until 56 M. pneumoniae isolates collected.

Interventions

OTHERNo Drug

It's a surveillance

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Chinese adult (male or female) ≥18 years old * Outpatients or inpatients who suffer from CAP

Exclusion criteria

Design outcomes

Primary

Measure	Time frame
In vitro Minimal Inhibitory Concentration Detection	Up to 27 months

Secondary

Measure	Time frame
In vitro Gene Mutation Detection	Up to 15 months

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026